Subvenite Tablet
Product Images NDC 69102-301

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Subvenite (NDC 69102-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Owp Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg 100 Count

Label for Subvenite 100 mg lamotrigine tablets, USP, shown as a 100-tablet package. The label includes storage instructions, caution to verify product dispensed, and dispensing guidance. Manufactured for OWP Pharmaceuticals, Inc., Naperville, IL, with country of origin India and an NDC number 69102-319-01.*

FDA Label Image

150mg 100 Count

Subvenite 150 mg lamotrigine tablets carton label for 100 tablets. The label features dosage strength, warnings to verify product dispensed and to dispense the Medication Guide, manufacturer information (OWP Pharmaceuticals, Inc.), storage instructions, and a barcode. The label indicates prescription use only.*

FDA Label Image

200mg 100 Count

Label for Subvenite (lamotrigine tablets, USP) 200 mg, packaged as 100 tablets, labeled by OWP Pharmaceuticals, Inc. The label includes caution and attention statements to verify product dispensed and provide the accompanying medication guide. It specifies storage instructions and indicates the product is Rx only with a country of origin of India.*

FDA Label Image

25mg 100 Count

Subvenite 25 mg lamotrigine tablets label for 100 tablets, manufactured by OWP Pharmaceuticals, Inc. The label displays dosage strength, active ingredient name, NDC 69102-301-01, storage instructions, and cautionary statement to dispense the accompanying Medication Guide. The product is prescription only.*

FDA Label Image

Figure 1 Subvenite

A Kaplan-Meier curve showing failure probability (%) over weeks for Lamotrigine versus placebo groups. The graph includes lines for both treatments with censored data points marked, illustrating lower failure probability for Lamotrigine compared to placebo over time.*

FDA Label Image

Figure 2 Subvenite

A survival curve chart showing failure probability (%) over weeks (0 to 80) comparing Placebo and Lamotrigine treatments. The chart includes censored data points, with the Placebo group showing higher failure probability compared to the Lamotrigine group over time.*

FDA Label Image

Structure (Structure)

Chemical structure of lamotrigine, the active ingredient in SUBVENITE.*

FDA Label Image

Tablet Image (Subvenite)

Dimensional drawing illustration of SUBVENITE (lamotrigine) tablets showing both upper and lower face impressions for four strengths: 25 mg tablet marked '2L', 100 mg tablet marked '10LA', 150 mg tablet marked '15LA', and 200 mg tablet marked '20LA'. Each strength is displayed with a circular outline and a scored lower face.*

FDA Label Image

Subvenite Sk Blue

Subvenite lamotrigine tablets USP 25 mg Blue Starter Kit packaging label showing dosage instructions for gradual dose increase over five weeks. The box contains 35 tablets and includes manufacturer OWP Pharmaceuticals, Inc. The label highlights tablet imprint 2L and storage conditions.*

FDA Label Image

Subvenite Sk Green

Packaging label of Subvenite (lamotrigine tablets, USP) Green Starter Kit by OWP Pharmaceuticals, Inc. The kit includes lamotrigine tablets in 25 mg and 100 mg strengths. The label details dosing instructions for weeks 1 to 5 with specific tablet counts per day, storage conditions, and a barcode. The design features a green color scheme with dosing instructions segmenting the kit contents by weeks and strengths.*

FDA Label Image

Subvenite Sk Orange

Packaging label for SUBVENITE lamotrigine tablets, USP Orange Starter Kit by OWP Pharmaceuticals, Inc. The kit contains tablets in strengths of 25 mg and 100 mg. The label includes dosing instructions for weeks 1 to 5 with specific tablet counts per day and storage information. The label also features barcodes and regulatory details on an orange and white background.*

FDA Label Image

Torrent Logo

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.